vs
ABVC BIOPHARMA, INC.（ABVC）与T Stamp Inc（IDAI）财务数据对比。点击上方公司名可切换其他公司
T Stamp Inc的季度营收约是ABVC BIOPHARMA, INC.的1.1倍（$908.9K vs $796.0K），ABVC BIOPHARMA, INC.净利率更高（-256.6% vs -279.9%，领先23.3%），ABVC BIOPHARMA, INC.同比增速更快（104.5% vs -39.3%），过去两年ABVC BIOPHARMA, INC.的营收复合增速更高（1041.5% vs 25.9%）
ABVC生物制药是一家处于临床阶段的生物制药企业，专注于开发肿瘤、眼科、中枢神经系统疾病等领域的创新治疗方案，业务覆盖北美及亚洲主要市场，多款自研候选药物正处于临床试验推进阶段。
T Stamp Inc（股票代码IDAI）研发并提供AI驱动的身份核验、信任评分与欺诈防护解决方案，服务覆盖金融科技、医疗健康、电商等领域，主要面向北美市场客户，助力企业安全验证用户身份、降低欺诈风险。
ABVC vs IDAI — 直观对比
营收规模更大
IDAI
是对方的1.1倍
$796.0K
营收增速更快
ABVC
高出143.8%
-39.3%
净利率更高
ABVC
高出23.3%
-279.9%
两年增速更快
ABVC
近两年复合增速
25.9%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $796.0K | $908.9K |
| 净利润 | $-2.0M | $-2.5M |
| 毛利率 | 100.0% | — |
| 营业利润率 | -246.8% | -224.9% |
| 净利率 | -256.6% | -279.9% |
| 营收同比 | 104.5% | -39.3% |
| 净利润同比 | -417.4% | 57.7% |
| 每股收益（稀释后） | $-0.09 | $-0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABVCIDAI
| Q4 25 | — | $908.9K | ||
| Q3 25 | $796.0K | $872.5K | ||
| Q2 25 | — | $812.7K | ||
| Q1 25 | — | $545.5K | ||
| Q4 24 | $2.0K | $1.5M | ||
| Q3 24 | $389.3K | $511.1K | ||
| Q2 24 | $117.1K | $500.4K | ||
| Q1 24 | $1.2K | $573.7K |
净利润ABVCIDAI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $-2.0M | $-1.9M | ||
| Q2 25 | — | $-1.7M | ||
| Q1 25 | — | $-2.2M | ||
| Q4 24 | — | $-6.0M | ||
| Q3 24 | $-394.8K | $-1.3M | ||
| Q2 24 | $-942.3K | $-2.6M | ||
| Q1 24 | $-2.8M | $-2.7M |
毛利率ABVCIDAI
| Q4 25 | — | — | ||
| Q3 25 | 100.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 100.0% | — | ||
| Q3 24 | 99.9% | — | ||
| Q2 24 | 99.8% | — | ||
| Q1 24 | 77.0% | — |
营业利润率ABVCIDAI
| Q4 25 | — | -224.9% | ||
| Q3 25 | -246.8% | -203.0% | ||
| Q2 25 | — | -207.0% | ||
| Q1 25 | — | -396.5% | ||
| Q4 24 | — | -81.2% | ||
| Q3 24 | -77.7% | -523.7% | ||
| Q2 24 | -734.2% | -524.7% | ||
| Q1 24 | -235539.8% | -496.7% |
净利率ABVCIDAI
| Q4 25 | — | -279.9% | ||
| Q3 25 | -256.6% | -219.1% | ||
| Q2 25 | — | -210.7% | ||
| Q1 25 | — | -395.5% | ||
| Q4 24 | — | -401.5% | ||
| Q3 24 | -101.4% | -245.7% | ||
| Q2 24 | -804.4% | -519.3% | ||
| Q1 24 | -235203.2% | -466.9% |
每股收益（稀释后）ABVCIDAI
| Q4 25 | — | $-0.37 | ||
| Q3 25 | $-0.09 | $-0.72 | ||
| Q2 25 | — | $-0.69 | ||
| Q1 25 | — | $-0.89 | ||
| Q4 24 | — | $-3.14 | ||
| Q3 24 | $-0.03 | $-1.06 | ||
| Q2 24 | $-0.08 | $-3.19 | ||
| Q1 24 | $-0.29 | $-3.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $257.2K | $6.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $12.1M | $8.7M |
| 总资产 | $21.2M | $11.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABVCIDAI
| Q4 25 | — | $6.0M | ||
| Q3 25 | $257.2K | $5.4M | ||
| Q2 25 | — | $292.1K | ||
| Q1 25 | — | $1.1M | ||
| Q4 24 | $313.1K | $2.8M | ||
| Q3 24 | $208.2K | $598.0K | ||
| Q2 24 | $200.0K | $659.5K | ||
| Q1 24 | $106.4K | $816.7K |
股东权益ABVCIDAI
| Q4 25 | — | $8.7M | ||
| Q3 25 | $12.1M | $6.1M | ||
| Q2 25 | — | $2.4M | ||
| Q1 25 | — | $4.1M | ||
| Q4 24 | $1.2M | $3.0M | ||
| Q3 24 | $1.6M | $5.4M | ||
| Q2 24 | $1.8M | $750.4K | ||
| Q1 24 | $1.7M | $1.4M |
总资产ABVCIDAI
| Q4 25 | — | $11.2M | ||
| Q3 25 | $21.2M | $11.2M | ||
| Q2 25 | — | $5.7M | ||
| Q1 25 | — | $6.6M | ||
| Q4 24 | $7.5M | $8.6M | ||
| Q3 24 | $7.8M | $10.6M | ||
| Q2 24 | $8.0M | $5.2M | ||
| Q1 24 | $8.0M | $5.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-964.7K | $2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $2.0M |
| 自由现金流率自由现金流/营收 | — | 215.4% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-5.7M |
8季度趋势，按日历期对齐
经营现金流ABVCIDAI
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-964.7K | $-4.0M | ||
| Q2 25 | — | $-2.1M | ||
| Q1 25 | — | $-1.5M | ||
| Q4 24 | $-1.8M | $-2.7M | ||
| Q3 24 | $60.2K | $-2.4M | ||
| Q2 24 | $-211.4K | $-1.6M | ||
| Q1 24 | $-955.8K | $-2.2M |
自由现金流ABVCIDAI
| Q4 25 | — | $2.0M | ||
| Q3 25 | — | $-4.0M | ||
| Q2 25 | — | $-2.1M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | — | $-2.4M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $-2.2M |
自由现金流率ABVCIDAI
| Q4 25 | — | 215.4% | ||
| Q3 25 | — | -459.6% | ||
| Q2 25 | — | -258.6% | ||
| Q1 25 | — | -289.2% | ||
| Q4 24 | — | -182.9% | ||
| Q3 24 | — | -475.4% | ||
| Q2 24 | — | -320.9% | ||
| Q1 24 | — | -376.6% |
资本支出强度ABVCIDAI
| Q4 25 | — | 0.8% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 0.5% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
